Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Coleman

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Postgraduate Medical Journal|March 1, 1973
Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugationS R Mostow, S C Schoenbaum, W R Dowdle, et al.
Postgraduate Medical Journal|March 1, 1973
Inactivated influenza vaccines. 2. Laboratory indices of protectionW R Dowdle, M T Coleman, S R Mostow, et al.
Virology|August 1, 1975
Temperature sensitive mutants of influenza virus. IX. Genetic and biological characterization of TS-1[E] lesions when transferred to a 1972 (H3N2) influenza A virusD D Richman, B R Murphy, S B Spring, et al.
British Medical Journal|October 20, 1973
Antigenic variants of influenza B virusG C Schild, M S Pereira, P Chakraverty, et al.
American Journal of Epidemiology|October 1, 1970
Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in manS R Mostow, S C Schoenbaum, W R Dowdle, et al.
Bulletin of the World Health Organization|January 1, 1973
Influenzavirus neuraminidase and neuraminidase-inhibition test proceduresM Aymard-Henry, M T Coleman, W R Dowdle, et al.
The Journal of Infectious Diseases|June 1, 1976
Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trialR J Rubin, G R Noble, L Corey, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Postgraduate Medical Journal|March 1, 1973
Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugationS R Mostow, S C Schoenbaum, W R Dowdle, et al.
Postgraduate Medical Journal|March 1, 1973
Inactivated influenza vaccines. 2. Laboratory indices of protectionW R Dowdle, M T Coleman, S R Mostow, et al.
Virology|August 1, 1975
Temperature sensitive mutants of influenza virus. IX. Genetic and biological characterization of TS-1[E] lesions when transferred to a 1972 (H3N2) influenza A virusD D Richman, B R Murphy, S B Spring, et al.
British Medical Journal|October 20, 1973
Antigenic variants of influenza B virusG C Schild, M S Pereira, P Chakraverty, et al.
American Journal of Epidemiology|October 1, 1970
Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in manS R Mostow, S C Schoenbaum, W R Dowdle, et al.
Bulletin of the World Health Organization|January 1, 1973
Influenzavirus neuraminidase and neuraminidase-inhibition test proceduresM Aymard-Henry, M T Coleman, W R Dowdle, et al.
The Journal of Infectious Diseases|June 1, 1976
Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trialR J Rubin, G R Noble, L Corey, et al.
Pageof 3